๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Endometrioid Cancer

Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer NCT05945407NA1 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: Indication-extended Fertility-sparing Therapy A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003). NCT06843447Phase 1, Phase 239 sites๐Ÿ“ New Haven๐Ÿ“ Louisville๐Ÿ“ Shreveport Merck Sharp & Dohme LLC ยท Tests: Raludotatug Deruxtecan, Carboplatin, Paclitaxel, Bevacizumab, Rescue Medication Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study NCT06689956n/a20 sites๐Ÿ“ Rochester๐Ÿ“ New York๐Ÿ“ Houston Mayo Clinic ยท Tests: Non-Interventional Study Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy NCT07504588Phase 213 sites๐Ÿ“ Fayetteville๐Ÿ“ Rogers๐Ÿ“ Springdale National Cancer Institute (NCI) ยท Tests: Anti-VEGF Monoclonal Antibody, Bevacizumab, Biospecimen Collection, Carboplatin, Computed Tomography Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer NCT06580314Phase 3695 sites๐Ÿ“ Birmingham๐Ÿ“ Anchorage๐Ÿ“ Anchorage NRG Oncology ยท Tests: Bevacizumab, Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Olaparib ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer NCT05542407Phase 11 site๐Ÿ“ Chapel Hill UNC Lineberger Comprehensive Cancer Center ยท Tests: Atezolizumab, ONC201 Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma NCT05112601Phase 2138 sites๐Ÿ“ Birmingham๐Ÿ“ Athens๐Ÿ“ Augusta National Cancer Institute (NCI) ยท Tests: Biospecimen Collection, Computed Tomography, Ipilimumab, Magnetic Resonance Imaging, Nivolumab Study of NTB-928 in R/R OC NCT07690189Phase 14 sites๐Ÿ“ Birmingham๐Ÿ“ Omaha๐Ÿ“ Lake Success TeneoSeven, Inc. ยท Tests: NTB-928 A Study of Radspherinยฎ in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery NCT06504147Phase 210 sites๐Ÿ“ Tampa๐Ÿ“ Leuven๐Ÿ“ Roma Oncoinvent Solutions AS ยท Tests: Radspherin Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer NCT05080556Phase 21 site๐Ÿ“ London University College, London ยท Tests: Carboplatin Study of EV for Recurrent Endometrial Carcinoma NCT07139977Phase 21 site๐Ÿ“ Milwaukee William Bradley ยท Tests: Enfortumab Vedotin APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion NCT04919629Phase 21 site๐Ÿ“ Buffalo Roswell Park Cancer Institute ยท Tests: Bevacizumab, Biopsy, Biospecimen Collection, Pegcetacoplan, Pembrolizumab Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial Cancer NCT06468215NA1 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: Treatment Option 1 is a single-drug regimen, with oral medroxyprogesterone acetate (MPA) 500mg/d or MA 320mg/d. MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) NCT04111978Phase 353 sites๐Ÿ“ Graz๐Ÿ“ Graz๐Ÿ“ Innsbruck Swiss GO Trial Group ยท Tests: Letrozole 2.5mg, Placebo A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05) NCT07743164Phase 34 sites๐Ÿ“ Fountain Valley๐Ÿ“ Orlando๐Ÿ“ Tel Aviv Merck Sharp & Dohme LLC ยท Tests: R-DXd, Bevacizumab, Carboplatin, Paclitaxel, Gemcitabine CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer. NCT06690775Phase 266 sites๐Ÿ“ Phoenix๐Ÿ“ Tucson๐Ÿ“ Duarte TORL Biotherapeutics, LLC ยท Tests: TORL-1-23, TORL-1-23, TORL-1-23, Pegfilgrastim (drug) OV Precision: Study Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy NCT06466382NA10 sites๐Ÿ“ Baden๐Ÿ“ Basel๐Ÿ“ Sankt Gallen Swiss GO Trial Group ยท Tests: Treatment recommendation by molecular tumorboard (mTB) based on tumor profiling, Carboplatin / Paclitaxel Chemotherapy Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer NCT07736937Phase 1, Phase 28 sites๐Ÿ“ Los Angeles๐Ÿ“ East Brunswick๐Ÿ“ New York Gilead Sciences ยท Tests: TUB-040 + Carbo + BEV Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer NCT06617923Phase 22 sites๐Ÿ“ Baltimore๐Ÿ“ Philadelphia Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ยท Tests: Senaparib, Temozolomide A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib NCT05512208Phase 24 sites๐Ÿ“ Orlando๐Ÿ“ New Orleans๐Ÿ“ Albuquerque University of Oklahoma ยท Tests: Avutometinib (VS-6766) + defactinib Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial NCT07436793Phase 24 sites๐Ÿ“ Iowa City๐Ÿ“ Albuquerque๐Ÿ“ Salt Lake City New Mexico Cancer Research Alliance ยท Tests: Biopsy Procedure, Curettage Procedure, Hysterectomy, Megestrol Acetate, Progesterone Only Hormone Replacement Therapy Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer NCT05997017Phase 29 sites๐Ÿ“ Little Rock๐Ÿ“ Miami Beach๐Ÿ“ Las Vegas Aadi Bioscience, Inc. ยท Tests: nab-sirolimus PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer NCT06549855NA1 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: Sintilimab or Pembrolizumab and medroxyprogesterone acetate (MPA)/ megestrol acetate (MA) Trial of THEO-260 in Ovarian Cancer Patients NCT06618235Phase 1, Phase 24 sites๐Ÿ“ Madrid๐Ÿ“ Glasgow๐Ÿ“ London Theolytics Limited ยท Tests: THEO-260 Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer NCT03422198Phase 35 sites๐Ÿ“ Palo Alto๐Ÿ“ Maywood๐Ÿ“ Houston University of Utah ยท Tests: Vaginal Cuff Brachytherapy, Short course vaginal cuff brachytherapy Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial NCT04575935Phase 319 sites๐Ÿ“ Miami๐Ÿ“ Weston๐Ÿ“ Boston M.D. Anderson Cancer Center ยท Tests: Chemotherapy, Laparotomy, Minimally Invasive Surgery, Quality-of-Life Assessment, Questionnaire Administration PROfiling Based Endometrial Cancer Adjuvant Therapy NCT05179447NA10 sites๐Ÿ“ Wuhan๐Ÿ“ Jinan๐Ÿ“ Hangzhou Women's Hospital School Of Medicine Zhejiang University ยท Tests: Vaginal brachytherapy, External beam radiotherapy, Observation, Chemoradiation therapy Safety, Efficacy and Quality of Life After Adjuvant Hypofractionated Radiotherapy for Endometrial Cancer NCT07871838NA1 site๐Ÿ“ Montreal McGill University Health Centre/Research Institute of the Mโ€ฆ ยท Tests: Hypo fractionated RT Folate Receptor Alpha Dendritic Cells (FRฮฑDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial NCT06639074Phase 23 sites๐Ÿ“ Scottsdale๐Ÿ“ Jacksonville๐Ÿ“ Rochester Mayo Clinic ยท Tests: Biopsy, Biospecimen Collection, Computed Tomography, Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorโ€ฆ Trial of THEO-260 (Administered Via Intraperitoneal Route) in Ovarian Cancer Patients NCT07211659Phase 11 site๐Ÿ“ Houston Theolytics Limited ยท Tests: THEO-260
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy